Biotechnology News

May 16, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals from non-petroleum sources, announced the appointment of Ray W. Miller as Chief Business Officer. Mr....

May 16, 2012

MADISON, Wis.--(BUSINESS WIRE)--Nine Wisconsin biotechnology companies have been awarded scholarships to support attending the Biotechnology Industry Organization’s (BIO) International Convention in Boston, MA. June 18-21, 2012.

May 16, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix announced that six posters on its iCALM™ and iSPERSE™ inhaled drug platforms have been selected for presentation at the American Thoracic Society (ATS) 2012 International Conference.

May 16, 2012

BOSTON--(BUSINESS WIRE)--The Biodesign Institute® at Arizona State University selects HighRes Biosolutions to automate DNA sample prep of Nucleic Acid Programmable Protein Arrays using a dual NanoCell™ lab automation system.

May 16, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign, a cardiac device company leading the way in percutaneous mitral valve repair, today announced the closing of a $35M Series D round of funding.

May 16, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--DNAnexus, a DNA data management and analysis platform, has announced the appointment of Marc Olesen as President and COO.

May 16, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO) (www.internationalstemcell.com) today announced financial results for...

May 16, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--As awareness activities take place today across the globe in recognition of Hereditary Angioedema (HAE) Day –– Dyax Corp. (NASDAQ: DYAX) has announced a donation of $25,000 to the United States Hereditary...

May 16, 2012

SEATTLE--(BUSINESS WIRE)--NanoString Technologies today announced the initiation of the second clinical validation study of its PAM50-based breast cancer assay.

May 16, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that there will be four presentations at the upcoming 2012 American College of...

May 16, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) reiterated its slate of activities in conjunction with the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held June 1-5, 2012, in Chicago...

May 16, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), today announced that the Company’s Chief Science Officer, Edward Wirth III, MD, PhD will be presenting at the Interdependence 2012 show currently being held in...

May 16, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC, Amarantus Move Forward with Joint Venture Discussions

May 16, 2012

TOKYO--(BUSINESS WIRE)--Sorin Group announces authorization from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to market MEMO 3D Semi-Rigid Annuloplasty Ring and first implant at the Kobe City Medical Cent

May 16, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company will present important new data from studies of several of its cancer medicines at the 48th Annual...

May 15, 2012

DURHAM, N.C.--(BUSINESS WIRE)--HyperBranch Medical Technology, Inc. announced today that it has received CE Marking for AdherusTM AutoSpray Dural Sealant. Adherus AutoSpray is a novel delivery system used for the delivery of HyperBranch’s dural...

May 15, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for its first quarter ended March 31, 2012. Full financial statements and...

May 15, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (Nasdaq:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the United States Patent and...

May 15, 2012

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $...

May 15, 2012

PARIS--(BUSINESS WIRE)--As EuroPCR 2012 gets under way today, Medtronic, Inc. (NYSE: MDT) announced that the Resolute Integrity Coronary Stent System has received European regulatory approval for several new indications, making it the drug-...

May 15, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Minnetronix will bring its first proprietary medical technology to the marketplace via a licensing agreement with Penn State Research Foundation.

May 15, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics has initiated a Phase 1/2 trial of a novel combination therapy for advanced metastatic melanoma: GM-CT-01, a galectin inhibitor compound with a peptide vaccine.

May 15, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Achaogen, Inc. announced today that all objectives were met in the company's multi-national Phase 2 study of plazomicin compared to levofloxacin for the treatment of complicated urinary tract...

May 15, 2012

CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc. (NYSE: GB), today announced that Mr. Thomas J. Hook, President and CEO will present at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, NV on Tuesday, May 15, 2012, at...

May 15, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s biologics manufacturing facility in Devens, Massachusetts for commercial production of...

May 15, 2012

--(BUSINESS WIRE)--Biotechnology Information Organization (BIO):   WHAT: The Subcommittee on Conservation, Energy and Forestry is holding a public hearing regarding Formulation of the 2012 Farm Bill: Energy and Forestry Programs. This continues a...

May 15, 2012

KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (ABMC.PK) today announced financial results for the three months ended March 31, 2012. Net sales for the first quarter of 2012 were $2,296,000, an increase of $249,000, or 12.2%,...

May 15, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG) has been granted NOK 7.8 million of the Norwegian Research Council`s BIA funds. The funds will be employed in an industry-oriented research project to improve robustness and...

May 15, 2012

MALVERN, Penn.--(BUSINESS WIRE)--Promedior announced the appointment of Suzanne L. Bruhn, Ph.D., as President and Chief Executive Officer. Promedior will move its headquarters and operations to the Boston area.

May 15, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the Company will be added to the NASDAQ Biotechnology Index® (NBI), effective prior to market open on Monday, May 21, 2012. The NBI includes...

May 15, 2012

EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA has expanded its social housing program with the addition of new enrichment tunnels and NHP European–compliant group housing capabilities.

May 15, 2012

TAINAN, Taiwan--(BUSINESS WIRE)--Research and License agreements between National Cheng Kung University and Novo Nordisk A/S

May 15, 2012

ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--Priliminary findings from St. Jude Medical sponsored FAME II Trial demonstrate FFR-guided PCI is superior to medical treatment alone. Risk of urgent revascularization reduced by more than 11 times.

May 15, 2012

GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--AxioMed® Spine Corporation (www.axiomed.com) announces the receipt of CE Mark approval for its Freedom® Cervical Disc, an elastomeric total...

May 15, 2012

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB:FCSC.OB) announced today the formation of the Clinical Investigations for Dermal Mesenchymally-Obtained Derivatives (CIDMOD) Initiative (...

May 15, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

May 15, 2012

PROVIDENCE, R.I.--(BUSINESS WIRE)--Beech Tree Labs appoints William J. Ryan to Board of Directors. Beech Tree is a leader in novel molecular signaling technology.

May 15, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix presented positive preclinical data on its iSPERSE™ inhaled drug delivery platform at Respiratory Drug Delivery 2012, which is being held May 13-17, 2012, in Phoenix, AZ.

May 15, 2012

MIAMI--(BUSINESS WIRE)--Mind Gamz added three (3) new patients to analyze for the iPhone therapy game “Think Like a Shrink.” The update includes an expanded Reference Guide, new defenses, leaderboards, and achievements.

May 15, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Friday, June 1, 2012, in New York City from 9:00 a.m. to approximately 1:00 p.m. Eastern Daylight Time. The meeting will include...

May 15, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthLeaders-InterStudy, the leading provider of managed care market intelligence, finds that the next wave of growth for health plans will come from states looking to them for experience with coordinated care...

May 15, 2012

SEATTLE--(BUSINESS WIRE)--Theraclone Sciences announces positive results of its Phase 1 clinical trial of therapeutic antibody TCN-032 for the treatment of influenza A.

May 15, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced a reverse split of its common stock at a ratio of 1-for-7. CytRx’s common stock will begin trading on NASDAQ on...

May 15, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT) today reported financial results for the third quarter of fiscal year 2012 which ended on March 31, 2012. Highlights of the third quarter...

May 15, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Biomarkers for drug development in CNS disease and personalized medicine applications to be discussed by KineMed CEO David Fineman at the 7th annual Neurotech Investing & Partnering Conference

May 15, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia produces precisely engineering particles with controlled shape, size, and chemistry, all characteristics that could lead to better lung delivery and performance of respiratory therapeutics...

May 15, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the quarter ended March 31, 2012. Highlights for the First Quarter of 2012: BL-7040 - Received...

May 15, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO) (www.internationalstemcell.com) today announced that several of its...

May 15, 2012

SAN ANTONIO--(BUSINESS WIRE)--Jim Cunniff Named Senior Vice President, Leading Commercial Activities in the Americas for KCI